Genes, Immunoglobulin Heavy Chain
"Genes, Immunoglobulin Heavy Chain" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Genes and gene segments encoding the IMMUNOGLOBULIN HEAVY CHAINS. Gene segments of the heavy chain genes are symbolized V (variable), D (diversity), J (joining), and C (constant).
Descriptor ID |
D050438
|
MeSH Number(s) |
G05.360.340.024.340.335.300
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Genes, Immunoglobulin Heavy Chain".
Below are MeSH descriptors whose meaning is more specific than "Genes, Immunoglobulin Heavy Chain".
This graph shows the total number of publications written about "Genes, Immunoglobulin Heavy Chain" by people in this website by year, and whether "Genes, Immunoglobulin Heavy Chain" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2013 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genes, Immunoglobulin Heavy Chain" by people in Profiles.
-
Composite lymphoma of follicular B-cell and peripheral T-cell types with distinct zone distribution in a 75-year-old male patient: a case study. Hum Pathol. 2018 06; 76:110-116.
-
Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol. 2016 09; 55:39-43.
-
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 07; 121(10):1795-804.
-
Evolution of the V, D, and J gene segments used in the primate gammadelta T-cell receptor reveals a dichotomy of conservation and diversity. Proc Natl Acad Sci U S A. 2011 Jul 19; 108(29):E332-40.
-
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712. J Clin Oncol. 2011 Apr 01; 29(10):1349-55.
-
High-throughput sequencing of the zebrafish antibody repertoire. Science. 2009 May 08; 324(5928):807-10.
-
Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol. 2007 Jul 15; 179(2):1340-52.
-
Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes. BMC Immunol. 2006 Mar 20; 7:3.
-
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. J Clin Oncol. 2006 Jan 20; 24(3):437-43.